Feb 08, 2018 13:32 pm UTC| Business
CAMBRIDGE, Mass., Feb. 08, 2018 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare...
Feb 08, 2018 13:32 pm UTC| Business
HAYWARD, Calif., Feb. 08, 2018 -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including...
Arbutus Consolidates HBV Business Around Warminster, PA Site
Feb 08, 2018 13:32 pm UTC| Business
VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 08, 2018 -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced a site...
Feb 08, 2018 13:32 pm UTC| Business
NEW YORK, Feb. 08, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tanger Factory...
Feb 08, 2018 13:32 pm UTC| Business
Management to Host Shareholder Update Conference Call to Discuss Crane Creek and Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 08, 2018 -- First Choice...
Ultragenyx to Present at Leerink Partners Global Healthcare Conference
Feb 08, 2018 13:32 pm UTC| Business
NOVATO, Calif., Feb. 08, 2018 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini...
California State Court Rules in Favor of CP Kelco in Trade Secrets Theft Case
Feb 08, 2018 13:32 pm UTC| Business
ATLANTA, Feb. 08, 2018 -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that a California state court issued a judgment in its favor in a legal case filed against one of its...